Literature DB >> 25703548

What can immunology contribute to the control of the world's leading cause of death from bacterial infection?

Carl Nathan1.   

Abstract

Video podcast available Go to www.immunologicalreviews.com to watch an interview with Guest Editor Carl Nathan.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25703548      PMCID: PMC4339219          DOI: 10.1111/imr.12277

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  31 in total

1.  Antibiotics at the crossroads.

Authors:  Carl Nathan
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

2.  The equilibria that allow bacterial persistence in human hosts.

Authors:  Martin J Blaser; Denise Kirschner
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

3.  Aligning pharmaceutical innovation with medical need.

Authors:  Carl Nathan
Journal:  Nat Med       Date:  2007-03       Impact factor: 53.440

4.  Taming tuberculosis: a challenge for science and society.

Authors:  Carl Nathan
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

5.  Antibiotic resistance--problems, progress, and prospects.

Authors:  Carl Nathan; Otto Cars
Journal:  N Engl J Med       Date:  2014-10-01       Impact factor: 91.245

Review 6.  MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis.

Authors:  Marielle C Gold; Ruth J Napier; David M Lewinsohn
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 7.  Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus.

Authors:  Katharina Ronacher; Simone A Joosten; Reinout van Crevel; Hazel M Dockrell; Gerhard Walzl; Tom H M Ottenhoff
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 8.  Release of mycobacterial antigens.

Authors:  Laleh Majlessi; Rafael Prados-Rosales; Arturo Casadevall; Roland Brosch
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 9.  Fresh approaches to anti-infective therapies.

Authors:  Carl Nathan
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

Review 10.  Co-evolution of Mycobacterium tuberculosis and Homo sapiens.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

View more
  3 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

2.  Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.

Authors:  Matthew F Wipperman; Daniel W Fitzgerald; Marc Antoine Jean Juste; Ying Taur; Sivaranjani Namasivayam; Alan Sher; James M Bean; Vanni Bucci; Michael S Glickman
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

3.  Implementing Tuberculosis Close-contact Investigation in a Tertiary Hospital in Iran.

Authors:  Masoud Shamaei; Shahrbanoo Esmaeili; Majid Marjani; Payam Tabarsi
Journal:  Int J Prev Med       Date:  2018-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.